Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $276.86M.
ENTERPRISE VALUE (EV)
$276.86M
Indaptus Therapeutics, Inc.
Market Cap
$285.37M
Enterprise Value (EV)
$276.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | $285.37M | $276.86M |
| Standard BioTools Inc. (LAB)vs › | $287.22M | $45.28M |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | $240.26M |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.11M | $251.75M |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $289.59M | $238.04M |
| Aurora Cannabis Inc. (ACB)vs › | $279.98M | $212.57M |
| Fate Therapeutics, Inc. (FATE)vs › | $277.62M | $320.87M |
| SAB Biotherapeutics, Inc. (SABS)vs › | $276.93M | $273.79M |
| Larimar Therapeutics, Inc. (LRMR)vs › | $294.51M | $206.78M |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.08M | $74.37M |
Market Cap
$285.37M
Total Debt
$0.00
Cash
$8.51M
Enterprise Value
$276.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
